These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29137236)

  • 1. The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy.
    Ding XQ; Zhao S; Yang L; Zhao X; Zhao GF; Zhao SP; Li ZJ; Zheng HC
    Oncotarget; 2017 Oct; 8(47):81953-81966. PubMed ID: 29137236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nucleocytoplasmic translocation of ING5 protein in breast cancer and its correlation with poor clinicopathological characteristics of breast cancer].
    Song Y; Zhao S; Qi F; Zheng H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):53-58. PubMed ID: 29595458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of ING5 expression in ovarian carcinogenesis and subsequent progression: a target of gene therapy.
    Zheng HC; Zhao S; Song Y; Ding XQ
    Oncotarget; 2017 Nov; 8(61):103449-103464. PubMed ID: 29262575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.
    Zhao S; Yang XF; Shen DF; Gao Y; Shi S; Wu JC; Liu HX; Sun HZ; Su RJ; Zheng HC
    Oncotarget; 2016 Aug; 7(34):54596-54615. PubMed ID: 27409347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy.
    Zhao S; Zhao ZJ; He HY; Wu JC; Ding XQ; Yang L; Jia N; Li ZJ; Zheng HC
    Oncotarget; 2017 Aug; 8(34):56558-56568. PubMed ID: 28915612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
    Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
    Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of ING5 in cancer: A tumor suppressor.
    Zheng HC; Xue H; Jiang HM
    Front Cell Dev Biol; 2022; 10():1012179. PubMed ID: 36425530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma.
    Li X; Nishida T; Noguchi A; Zheng Y; Takahashi H; Yang X; Masuda S; Takano Y
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1573-83. PubMed ID: 20182888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway.
    Zhao QY; Ju F; Wang ZH; Ma XZ; Zhao H
    Int J Clin Exp Med; 2015; 8(9):15498-505. PubMed ID: 26629040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways.
    Liu XL; Zhang XT; Meng J; Zhang HF; Zhao Y; Li C; Sun Y; Mei QB; Zhang F; Zhang T
    Oncotarget; 2017 Aug; 8(33):54265-54276. PubMed ID: 28903339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
    J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy.
    Zheng HC; Zhao S; Xue H; Zhao EH; Jiang HM; Hao CL
    Front Oncol; 2020; 10():613679. PubMed ID: 33425768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer.
    Barlak N; Capik O; Sanli F; Kilic A; Aytatli A; Yazici A; Ortucu S; Ittmann M; Karatas OF
    Cell Biol Int; 2020 Jan; 44(1):242-252. PubMed ID: 31475765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
    Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
    Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.
    Zheng HC; Liu JJ; Li J; Wu JC; Yang L; Zhao GF; Zhao X; Jiang HM; Huang KQ; Li ZJ
    Oncotarget; 2017 Apr; 8(14):23603-23612. PubMed ID: 28223542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional Regulation of ING5 and its Suppressive Effects on Gastric Cancer.
    Zheng HC; Xue H; Wu X; Xu HL; Zhao EH; Cui ZG
    Front Oncol; 2022; 12():918954. PubMed ID: 35747809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.